Search

Displaying results 5701 - 5710 of 6834 in total
  1. Drug

    Porfiromycin

    go.drugbank.com/drugs/DB06478
    Investigational

    It belongs to the family of drugs called anticancer antibiotics.

  2. Drug

    4-Methyl-2,5-dimethoxyamphetamine

    go.drugbank.com/drugs/DB01528
    ExperimentalIllicit

    A psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of action may be similar to those of LSD.

  3. Drug

    (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium

    go.drugbank.com/drugs/DB02648
    Experimental

    It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem]

  4. Drug

    Olaflur

    go.drugbank.com/drugs/DB13290
    Investigational

    Olaflur which is also referred to as elmex gel is an ingredient used in toothpaste which helps in the prevention of dental caries.

  5. Drug

    CAR BCMA-CS1

    go.drugbank.com/drugs/DB17313
    Experimental

    CAR BCMA-CS1 is a lentiviral transfected chimeric antigen receptor (CAR) T-cell therapy modified to target B-cell maturation antigen and CS1.

    Synonyms: BCMA-CS1 cCAR T cell therapy
  6. Drug

    Bexmarilimab

    go.drugbank.com/drugs/DB16383
    Investigational

    Bexmarilimab is under investigation in clinical trial NCT03733990 (A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients).

  7. Drug

    XC221

    go.drugbank.com/drugs/DB16503
    Investigational

    XC221 was investigated in clinical trials to treat patients with respiratory infections, including influenza, COVID-19, and other acute viral upper respiratory infections.

  8. Drug

    Divesiran

    go.drugbank.com/drugs/DB18646
    Investigational

    Divesiran is a synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues.

  9. Drug

    Camoteskimab

    go.drugbank.com/drugs/DB18876
    Investigational

    Camoteskimab is under investigation in clinical trial NCT06436183 (A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis).

  10. Drug

    Semzuvolimab

    go.drugbank.com/drugs/DB18920
    Investigational

    Semzuvolimab is under investigation in clinical trial NCT03149211 (To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults).